JP2025514712A5 - - Google Patents
Info
- Publication number
- JP2025514712A5 JP2025514712A5 JP2024560880A JP2024560880A JP2025514712A5 JP 2025514712 A5 JP2025514712 A5 JP 2025514712A5 JP 2024560880 A JP2024560880 A JP 2024560880A JP 2024560880 A JP2024560880 A JP 2024560880A JP 2025514712 A5 JP2025514712 A5 JP 2025514712A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- carboxamide
- quinoline
- oxo
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2250473 | 2022-04-19 | ||
| SE2250473-2 | 2022-04-19 | ||
| PCT/US2023/019121 WO2023205251A1 (en) | 2022-04-19 | 2023-04-19 | Compounds active towards bromodomains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514712A JP2025514712A (ja) | 2025-05-09 |
| JP2025514712A5 true JP2025514712A5 (enExample) | 2026-04-27 |
Family
ID=86331094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560880A Pending JP2025514712A (ja) | 2022-04-19 | 2023-04-19 | ブロモドメインに対して活性な化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250382308A1 (enExample) |
| EP (1) | EP4511119A1 (enExample) |
| JP (1) | JP2025514712A (enExample) |
| CN (1) | CN119365455A (enExample) |
| AU (1) | AU2023255396A1 (enExample) |
| CA (1) | CA3255932A1 (enExample) |
| MX (1) | MX2024013002A (enExample) |
| WO (1) | WO2023205251A1 (enExample) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8476260B2 (en) | 2007-12-28 | 2013-07-02 | Mitsubishi Tanabe Pharma Corporation | Antitumor agent |
| GB0919431D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| EP2496580B1 (en) | 2009-11-05 | 2013-12-11 | GlaxoSmithKline LLC | Benzodiazepine bromodomain inhibitor |
| GB0919434D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| GB0919426D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
| SI2496582T1 (sl) | 2009-11-05 | 2016-04-29 | Glaxosmithkline Llc Corporation Service Company | Benzodiazepinski inhibitor bromodomene |
| MX384074B (es) | 2010-05-14 | 2025-03-12 | Dana Farber Cancer Inst Inc | Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos. |
| ES2526671T3 (es) | 2010-06-22 | 2015-01-14 | Glaxosmithkline Llc | Compuestos de benzotriazoldiazepina inhibidores de bromodominios |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2013027168A1 (en) | 2011-08-22 | 2013-02-28 | Pfizer Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| US20150344444A1 (en) | 2012-12-20 | 2015-12-03 | Bayer Pharma Aktiengesellschaft | Bet-protein-inhibiting dihydroxyquinoxalinones |
| CN105229002A (zh) | 2012-12-20 | 2016-01-06 | 拜耳医药股份有限公司 | 抑制bet蛋白的二氢吡啶并吡嗪酮 |
| ES2896400T3 (es) | 2014-08-01 | 2022-02-24 | Nuevolution As | Compuestos activos frente a bromdominios |
| CA3048602A1 (en) * | 2016-12-27 | 2018-07-05 | Fujifilm Corporation | Antitumor agent and bromodomain inhibitor |
-
2023
- 2023-04-19 JP JP2024560880A patent/JP2025514712A/ja active Pending
- 2023-04-19 CN CN202380043848.XA patent/CN119365455A/zh active Pending
- 2023-04-19 US US18/860,589 patent/US20250382308A1/en active Pending
- 2023-04-19 CA CA3255932A patent/CA3255932A1/en active Pending
- 2023-04-19 AU AU2023255396A patent/AU2023255396A1/en active Pending
- 2023-04-19 EP EP23723033.9A patent/EP4511119A1/en active Pending
- 2023-04-19 WO PCT/US2023/019121 patent/WO2023205251A1/en not_active Ceased
-
2024
- 2024-10-21 MX MX2024013002A patent/MX2024013002A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7514025B2 (ja) | Ｊａｋ阻害剤化合物及びその使用 | |
| AU2018208676B2 (en) | Macrocyclic compounds as trk kinase inhibitors | |
| JP7034133B2 (ja) | 感染性疾患の処置のためのカルボキシ ６，７－ジヒドロ－４Ｈ－ピラゾロ［１，５－ａ］ピラジン化合物 | |
| AU2025200658A1 (en) | Compounds, compositions and methods | |
| AU2017281228B2 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor M4 | |
| CN112778301A (zh) | 四氢吡啶并嘧啶类抑制剂及其制备方法和应用 | |
| AU2009257434B2 (en) | Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine H4 receptor | |
| CN115806550B (zh) | 双环bet布罗莫结构域抑制剂及其用途 | |
| CN112694475A (zh) | 环烷基类和杂环烷基类抑制剂及其制备方法和应用 | |
| CN115109078A (zh) | 嘧啶并吡啶类抑制剂及其制备方法和应用 | |
| CN113735879A (zh) | 一种大环jak抑制剂及其应用 | |
| AU2018320021C1 (en) | Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof | |
| AU2020268933B2 (en) | Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereof | |
| ES3062921T3 (en) | Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method | |
| CN112824410A (zh) | 氮杂七元环类抑制剂及其制备方法和应用 | |
| CA2657908A1 (en) | Benzofuro- and benzothienopyrimidine modulators of the histamine h4 receptor | |
| AU2020301437B2 (en) | Heterocyclic compounds for mediating tyrosine kinase 2 activity | |
| AU2021373162B2 (en) | Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof | |
| CN109721600B (zh) | 一类含氮稠环化合物及其制备方法和用途 | |
| CN112778336A (zh) | 一类含氮稠环类sting调节剂类化合物、制备方法和用途 | |
| WO2011152485A1 (ja) | 新規４，５－縮環ピリミジン誘導体 | |
| WO2024149389A1 (zh) | 取代桥环类抑制剂及其制备方法和应用 | |
| AU2022451580B2 (en) | Parp7 inhibitor and use thereof | |
| CN113045569A (zh) | 用作ret激酶抑制剂的化合物及其应用 | |
| CN116444497B (zh) | 一类哒嗪酮类化合物、制备及其应用 |